Remove digital predictions-ai-mental-health-coming-year
article thumbnail

DTx for women’s mental health – Woebot and postpartum depression

pharmaphorum

Digital therapeutics company Woebot Health has announced enrolment of the first patient in a pivotal clinical trial to evaluate the safety and efficacy of WB001, an investigational therapeutic for postpartum depression (PPD), granted Breakthrough Device designation by the US Food and Drug Administration (FDA) in 2021.

In-Vivo 102
article thumbnail

How AI in pharma can live up to the hype 

Drug Discovery World

Ben Folwell, Principal Consultant at Citeline, maps out how AI, swarm learning and open access to clinical data could revolutionise drug discovery. . Artificial intelligence (AI) is notorious for its industry hype, touted to revolutionise the way multiple sectors operate over the next five to 10 years. The simple answer is no.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What Matters Most: The Trends That Will Shape Pharma Marketing in 2022

Intouch Solutions

” It’s time to examine the ways in which our lives — and those of our patients, our caregivers, our HCPs, and all other stakeholders — have changed in the past two years. Compounding the issue for healthcare marketers, healthcare is growing overall, with more and more drugs coming to market.

article thumbnail

For neurological disease, solving measurement is the first and biggest hurdle to re-imagining treatment

pharmaphorum

Neurodegenerative diseases like Parkinson’s and Alzheimer’s affect millions of people worldwide, and their prevalence is only increasing, according to the World Health Organization. Utilising new digital technology, it turns out there are a number of ways to introduce objective measurement into the world of neurodegenerative diseases.

Trials 98
article thumbnail

Nine for 2021: The COVID-19 legacy

pharmaphorum

One bright spot in an otherwise dreadful year: the pharmaceutical industry has discovered it can do things it never dreamed possible. Anyone who proposed that a novel, deadly virus would spread, with a vaccine developed demonstrating 95% efficacy, and approved for patients in less than a year would have been scoffed at.

Sales 105
article thumbnail

Let's Quit Sugar With Audiobook – Let's Quit Sugar

The Pharma Data

First, you will learn how the food industry secretly tries to lure you into consuming junk food, so you always come back for more. All materials are DIGITAL and sent to you instantly in eBook or Audio format. At this moment, Let’s Quit Sugar is sold only in digital form. The trans-fat ban–food regulation and long-term health.

Insulin 52